Related Experiment Video
Updated: Mar 19, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Tools for Predicting the Functional Impact of Nonsynonymous Genetic Variation
1Division of Bioinformatics, Department of Preventive Medicine, University of Southern California, Los Angeles, California 90033.
Predicting the impact of nonsynonymous genetic variants on disease is crucial with widespread genome sequencing. This review covers current methods and challenges for prioritizing these variants accurately.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Personal genome sequencing is increasing, highlighting the need to understand genetic variant effects on phenotype.
- Nonsynonymous genetic variants, which alter protein amino acid sequences, are key targets for predicting phenotypic impact.
- Whole-genome sequencing generates numerous nonsynonymous variants, necessitating accurate computational prediction methods.
Purpose of the Study:
- To review existing computational methods for prioritizing nonsynonymous genetic variants.
- To discuss the underlying principles of these variant prediction methods.
- To identify challenges and future directions for improving nonsynonymous variant prediction.
Main Methods:
- Review of computational prioritization methods for nonsynonymous genetic variants.
- Analysis of the principles and algorithms underlying these prediction tools.
- Discussion of challenges in accurately predicting variant impact on phenotype.
Main Results:
- A review of current nonsynonymous variant prioritization methods and their foundational principles.
- Identification of key challenges hindering the accuracy of computational predictions.
- Discussion of areas for future development in variant effect prediction.
Conclusions:
- Accurate prediction of nonsynonymous variant effects is essential for interpreting personal genomes and understanding disease risk.
- Existing methods provide a foundation, but further advancements are needed to address prediction challenges.
- Improving computational tools will enhance the clinical utility of genomic data for disease prediction and treatment.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacogenomics: Identification of New Drug Targets
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Principles of Pharmacogenetics: Types of Genetic Variants

